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Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in tion in renal function [3]. In spite of the potential impor-
LLC-PK1 cells. tance of hypertrophy in renal disease, the cellular and
Background. Angiotensin II has been reported to induce molecular mechanisms leading to its development arerenal tubular hypertrophy, but the mechanisms of this hyper-
not well understood. A clear understanding of thesetrophy are not well known. We evaluated the roles of cyclin-
mechanisms may provide a basis for novel therapies independent kinase (CDK) inhibitors in renal tubular hyper-
trophy. the treatment of hypertrophic renal disorders.
Methods. To elucidate whether CDK inhibitors cause renal One possible mechanism is that hypertrophy repre-
tubular hypertrophy, we produced adenovirus vectors containing sents an aborted cell cycle, with cells entering the G1coding sequences of the CDK inhibitors p27Kip1 (AxCAp27),
phase and initiating protein synthesis and growth, butp21CIP1 (AxCAp21), and p16INK4 (AxCAp16), and we investigated
failing to progress into the S phase. The proliferation ofthe effect of these gene transfers on epidermal growth factor
(EGF)-induced proliferation in LLC-PK1 cells. We evaluated eukaryotic cells is tightly regulated through a precious
the cell cycle and hypertrophy by measurements of the [3H]- balance of positive and negative regulatory proteins that
leucine and [3H]-thymidine incorporation, the protein:DNA exert their effects during the first gap phase (G1) of theratio, flow cytometry, and CDK4 and CDK2 kinase assays.
cell cycle [4–6]. Stimulation of quiescent cells to re-enterResults. AxCAp27 and AxCAp21 caused significant increases
in [3H]-leucine incorporation and the protein:DNA ratio but the cell cycle induces the accumulation of G1 cyclins
did not change the [3H]-thymidine incorporation. Conversely, (three types of cyclin D and cyclin E), thereby activating
AxCAp16 inhibited EGF-stimulated [3H]-thymidine incorpo- associated cyclin-dependent kinases (CDKs). This leads
ration but did not change the [3H]-leucine incorporation. Ax-
to the phosphorylation of downstream targets and anCAp27, AxCAp21, and AxCAp16 all inhibited EGF-stimu-
eventual entry into the S phase. The activity of theselated CDK4 kinase activity (to 15.6, 14.1, and 21.9% of control,
respectively). Forward light-scatter analysis demonstrated that G1 cyclin kinases is modulated by a family of proteins,
AxCAp27 and AxCAp21 increased the cell size but that Ax- including p21CIP1, p16INK4, and p27Kip1 [5, 7–14], and this
CAp16 effected no change in cell size. modulation defines a part of the negative control of the
Conclusion. These findings suggest that p27Kip1 and p21CIP1
G1 phase. There are at least two distinct families of CDKmay play an important role in hypertrophy of renal tubule cells
inhibitors in mammalian cells: the p21/p27 family andby reducing pRb phosphorylation. On the other hand, p16INK4
was not found to cause hypertrophic changes in EGF-treated the p15/p16 family [5, 6]. p21CIP1 and p27Kip1 proteins share
LLC-PK1 cells. considerable sequence homology and have been shown
to potently inhibit almost all cyclin-CDK enzymes [5,
13, 14]. In contrast, the p16 family specifically interacts
Renal tubular hypertrophy is an adaptive process that with CDK4 and CDK6 [5, 10, 11]. We reported recently
occurs in diabetes mellitus, when there is a loss of renal that the overexpression of p16INK4 and p21CIP1 inhibited
mass, during protein feeding, and a number of other the proliferation of mesangial cells induced by growth-
conditions [1, 2]. In many of these conditions, this hyper- promoting factors [15, 16].
trophy has been postulated to cause a progressive reduc- Angiotensin II (Ang II) and transforming growth
factor-b (TGF-b) have recently been reported to cause
hypertrophy in renal tubules [17, 18]. Preisig et al haveKey words: renal hypertrophy, cyclin-dependent kinase inhibitors,
phosphorylation, CDK4, adenovirus shown that there are two mechanisms of hypertrophy in
renal epithelial cells: a cell-cycle–dependent form andReceived for publication December 23, 1998
an alkalinization-induced hypertrophy form [1, 18, 19].and in revised form March 9, 1999
Accepted for publication March 16, 1999 Wolf and Stahl showed that Ang II stimulated the ex-
pression of p27Kip1 and that this p27Kip1 induction was 1999 by the International Society of Nephrology
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closely related to hypertrophy [2, 17]. These studies have serum, 100 units/ml penicillin, and 100 mg/ml streptomy-
cin at 378C in a 5% CO2 incubator.suggested that the mechanisms of hypertrophy may be
The cells were subcultured in 10 cm dishes or 24-wellclosely related to cell-cycle regulation, especially CDK
dishes at a density of 5 3 104 cells/ml and were thenactivity and CDK inhibitors. However, there has been
incubated in medium plus 10% fetal calf serum (FCS)no direct evidence confirming a relationship between
until approximately 70% confluence. Before adenovirusCDK inhibitors and hypertrophy.
infection, the cells were incubated in medium withoutThe purpose of this study is to determine whether
FCS for 24 hours. After removal of the medium, viralCDK inhibitors play key roles in the mechanisms of renal
solutions were added to the culture dishes for one hourtubular hypertrophy. We investigated how overexpres-
with shaking every 20 minutes. The cells were incubatedsion of the CDK inhibitors (p27Kip1, p21CIP1, and p16INK4)
in a medium containing 1028 m epidermal growth factorin LLC-PK1 cells affected the hypertrophic changes. As
(EGF; Boehringer, Mannheim, Germany) or 10% FCSa result, we found that overexpression of p27Kip1 and
for indicated times.p21CIP1 caused hypertrophy in LLC-PK1 cells but that
p16INK4 had no such effect.
Detection of b-galactosidase activity
Histological staining of b-galactosidase was conducted
METHODS as previously described [15]. In brief, the cells were
washed twice with phosphate-buffered saline (PBS),Recombinant adenoviruses
fixed with 80% ethanol for 10 minutes at 48C, washedReplication-defective, recombinant adenoviruses Ax-
another four times with PBS, and incubated in stainingCAp16, AxCAp21, and AxCAp27 were constructed by
solution for four hours at 378C. The staining solutionhomologous recombination between the expression cos-
was comprised of 1 mg/ml 5-bromo-4-chloro-3-indolyl-mid cassette and the parental virus genome using the
D-galactopyranoside (X-gal), 2 mm MgCl2, 5 mm K4Fesame method described previously [15, 20, 21]. Briefly,
(CN)6, and 5mm K4Fe (CN)6 in 100 mm sodium phosphatethe expression cosmid cassette was constructed by in-
buffer (pH 7.4). b-galactosidase activity was detectedserting an expression unit comprised of the polyA se-
as the development of blue pigmentation due to thequence together with the CAG (chicken b-actin pro-
enzymatic cleavage of X-galactosidase.moter 1 cytomegalovirus enhancer) promoter [21],
p16INK4, p21CIP1, p27Kip1, or LacZ coding sequence into the Antibodies
SwaI site of Adex1w. The expression cosmid cassette Antibodies against antimouse-p27Kip1, antimouse-cyclin
and adenovirus DNA-terminal protein complex (DNA- D1, and antimouse-cyclin E were purchased from Santa
TPC) were cotransfected into 293 cells by the calcium Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies
phosphate precipitation method as described previously against antihuman-p21CIP1 and antihuman-p16INK4 were
[15, 20, 21]. Adex1w and DNA-TPC were kindly pro- purchased from Pharmigen (San Diego, CA, USA).
vided by Dr. I. Saito [20, 21]. The full-length rat p21CIP1
cDNA (2.1 kb; kindly provided by Dr. A. Noda) [7], Western blot analysis
human p27Kip1 cDNA (2.0 kb; kindly provided by Dr. T. The proteins were extracted from mesangial cells at
Hunter) [14], and human p16INK4 cDNA (1.8 kb; kindly 12, 24, and 48 hours after adenovirus infection using
provided by Dr. E. Hawlow) [22] were isolated by restric- Tri-Reagent. Pellets were solubilized in sodium dodecyl
tion enzyme, digested, and ligated into the SmaI site sulfate (SDS) sample buffer. Fifty micrograms of each
of the expression cosmid cassette with T4 DNA ligase protein were resolved in SDS-polyacrylamide gel elec-
(Takara, Tokyo, Japan) using essentially the same trophoresis, and the proteins were then transferred to an
method reported previously [15, 20, 21]. Immobilon P membrane (Daiichikagaku, Tokyo, Japan).
A recombinant adenovirus expressing the LacZ gene To detect p16INK4, p21CIP1, p27Kip1, cyclin D1, and cyclin
(AxCALacZ) was provided by Dr. I. Saito [20, 21]. Each E, the membrane was incubated with antibody at a dilu-
adenovirus preparation was titrated by plaque assay on tion of 1:500 in TBS containing 0.1% Tween 20 for two
293 cells. Viral stocks [1011 plaque-forming units (pfu)/ml] hours at 378C. The primary antibodies (diluted 1/1000)
were stored at 2808C and were thawed on ice for five were detected using horseradish peroxidase (HRP)-con-
minutes before use. jugated rabbit antimouse IgG or goat antirabbit IgG and
were visualized by the Amersham ECL system (Amer-
Cell culture sham Corp., Arlington Heights, IL, USA) after extensive
LLC-PK1 is a well-characterized renal tubular epithe- washing of the membranes.
lial cell line (American Type Culture Collection, Rock-
[3H]-leucine and [3H]-thymidine incorporationville, MD, USA). The cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM; GIBCO, Eggen- LLC-PK1 cells were plated in 24-well plates, incubated
in medium without FCS for 24 hours, and then infectedstein, Germany) supplemented with 10% fetal bovine
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with various concentrations of adenovirus for one hour. thovanadate (Sigma Chemicals, St. Louis, MO, USA)
and were sonicated at 48C (Sonicator; Daiichikagaku,Next, the cells were incubated for 48 hours in medium
containing Ang II (1027 to 1029 m) or 1028 m EGF, with Tokyo, Japan). Lysates were clarified by centrifugation
at 10,000 3 g for five minutes. The supernatants werepulsing with 1 mCi [3H]-leucine or [3H]-thymidine for the
last six or four hours, respectively (Amersham). After incubated for two hours at 48C with 20 ml of protein G-
plus agarose (Oncogene Science, Uniondale, NY, USA)the cells were washed three times in ice-cold PBS, they
were precipitated twice with 10% trichloroacetic acid and 10 ml of antimouse-CDK4 antibody or antimouse-
CDK2 antibody, and immune complexes were recover-(TCA), redissolved in 0.5 m NaOH with 0.1% Triton
X-100, and counted in Aquasol-2 scintillation cocktail ed by centrifugation. Immunoprecipitated proteins on
beads were washed three times with 1 ml of IP buffer,(NEN Research Products, Boston, MA, USA). To cor-
rect the [3H]-thymidine incorporation values by protein and the beads were suspended in 30 ml of kinase buffer
(50 mm HEPES, pH 7.5, 10 mm MgCl2, 1 mm DTT)contents, we measured the protein contents in each well
using a protein assay kit (Bio-Rad, Tokyo, Japan). containing substrate (0.2 mg of soluble glutathione S-
transferase-pRb fusion protein, which is discussed later
Cell cycle analysis by fluorescence-activated cell in this article, or 0.2 mg of Histon H1; Sigma), 2.5 mm
sorter analysis EGTA, 10 mm b-glycerophosphate, 1 mm NaF, 20 mm
ATP, and 10 mCi of [g-32P] ATP (6000 Ci/mmol; NEN,LLC-PK1 cells were cultured in a 10 cm dish and incu-
bated in medium without FCS for 24 hours before adeno- Dupont). After incubation for 30 minutes at 308C with
occasional mixing, the samples were boiled in polyacryl-virus infection. After removal of the medium, viral solu-
tions were added to the culture dishes for one hour, amide gel sample buffer containing SDS and were sepa-
rated by electrophoresis. Phosphorylated proteins wereand the cells were then incubated in a second medium
containing 1028 m EGF for 48 hours. The samples to be visualized by autoradiography.
pRb substrate was prepared using essentially the sameanalyzed for DNA content were harvested by trypsiniza-
tion and centrifugation, washed twice with PBS, and method described by Matsushime et al [24]. The concen-
tration and purity of soluble pRb were estimated byresuspended in 70% ethanol for at least 12 hours at 48C.
After the fixed and permeabilized cells were collected Coomassie blue staining of electrophoretically separated
proteins on denaturing polyacrylamide gels and compari-by centrifugation and washed with PBS, they were stained
with propidium iodide, analyzed by a flow cytometer, and sons with protein standards of known concentrations.
investigated by forward-angle light scatter to determine
Statisticsrelative cell size [18, 23]. All experiments were repeated
at least three times. The results were given as means 6 sem. The differ-
ences were tested using analysis of variance. A P , 0.05
Measurement of cell protein and DNA was considered significant.
LLC-PK1 cells were grown in six-well dishes and
washed with PBS, harvested with 0.25% trypsin and 0.5
RESULTS
mm ethylenediaminetetraacetic acid (EDTA) for five
Ang II causes hypertrophy and regulates p21CIP1 andminutes, and pelleted at 1500 g for five minutes. Each
p27Kip1 protein expression of LLC-PK1 cellspellet was resuspended in 1 ml lysis buffer (50 mm
Na2PO4, pH 7.4), and the cells were lyzed on ice by We first tested whether the treatment of LLC-PK1
cells with Ang II would stimulate hypertrophy. As shownrepeated passage through a 27-gauge needle. Next, the
DNA and protein contents were determined as pre- in Figure 1, treatment with 1027 and 1028 Ang II for 48
hours caused significant increases in [3H]-leucine incor-viously reported [18, 19].
poration and significant decreases in [3H]-thymidine in-
CDK4 and CDK2 kinase assay corporation. As shown in Figure 1C, Ang II caused a
significant increase in the protein:DNA ratio. These re-Immune complex kinase assay was performed by es-
sentially the same methods described by Matsushime et sults indicate that Ang II caused hypertrophy of LLC-
PK1 cells.al [24]. The cells were suspended at 1 3 106 to 5 3 106/ml
in IP buffer [50 mm N-2-hydroxyethylpiperazine-N9-2- We examined how Ang II regulated the protein ex-
pressions of p21CIP1, p27Kip1, p16INK4, cyclin D1, and cyclinethanesulfonic acid (HEPES; pH 7.5), 150 mm NaCl, 1
mm EDTA, 2.5 mm ethylene glycol-bis (b-aminoethyl- E. As shown in Figure 2, Western blots for p27Kip1 and
p21CIP1 revealed dose-dependent increases in the expres-ether)-N,N,N9,N9-tetraacetic acid (EGTA), 1 mm dithio-
threitol (DTT), 0.1% Tween-20] containing 10% glyc- sion of both proteins in the presence of Ang II. The
expression of p16INK4 protein is generally very low, anderol, 0.1 mm phenylmethylsulfonyl fluoride, 10 mg of
leupeptine per ml, 20 U of aprotinin per ml, 10 mm it did not significantly change in the presence of Ang
II in our experimental condition. Cyclin D1 expressionb-glycerophosphate, 1 mm NaF, and 0.1 mm sodium or-
Terada et al: Hypertrophy and CDK inhibitors 497
Fig. 1. Effect of angiotensin II (Ang II) on
[3H]-leucine and [3H]-thymidine incorpora-
tion and the protein:DNA ratio in LLC-PK1
cells. (A) LLC-PK1 cells incubated for 48
hours in serum-free medium. The cells were
incubated in mediums with various concentra-
tions of Ang II for 48 hours. For the last four
hours, the cells were pulsed with 1 mCi [3H]-
thymidine. (B) LLC-PK1 cells incubated for
48 hours in serum-free medium. The cells were
incubated in mediums with various concentra-
tions of Ang II for 48 hours. For the last six
hours, the cells were pulsed with 1 mCi [3H]-
leucine. (C) LLC-PK1 cells incubated for 48
hours in serum-free medium. The cells were
incubated in mediums with various concentra-
tions of Ang II for 48 hours. The ratio of
protein:DNA is plotted on the y axis as a
percentage of control values (cells treated
with vehicles only; N 5 5, mean 6 sem). *Sta-
tistically significant difference (P , 0.05) com-
pared with control data obtained from LLC-
PK1 cells incubated without Ang II.
Fig. 3. Dose-dependent expressions of p21C1P1, p27Kip1, and p16INK4 using
adenovirus vector. LLC-PK1 cells were infected with various concentra-
tions of AxCAp16, AxCAp21, AxCAp27, or vehicle control for one
hour. Total protein was harvested at 48 hours after infection. Fifty
micrograms of protein were used for Western blot analysis. The 21 kDa
for p21CIP1 protein, the 27 kDa for p27Kip1 protein, and the 16 kDa for
p16INK4 protein are observed. These blots represent four independent
experiments with qualitatively similar changes.
Fig. 2. Effect of Ang II on protein expressions of p21C1P1, p27Kip1, p16INK4,
cyclin D1, and cyclin E. LLC-PK1 cells incubated for 48 hours in medi- cells, we used adenovirus-mediated gene transfer ofums with or without Ang II (1027 to 1029 m). A total of 50 mg of protein
from each cellular lysate was separated by sodium dodecyl sulfate- p21CIP1, p27Kip1, and p16INK4 to LLC-PK1 cells. Specifically,
electrophoresis. The blots represent four independent experiments with we tested whether the AxCAp21, AxCAp27, and Ax-
qualitatively similar changes.
CAp16 adenoviruses express the p21CIP1, p27Kip1, and
p16INK4 proteins in LLC-PK1 cells. The protein expression
was detected at 12 to 48 hours after infection, which
showed a significant dose-dependent increase in the pres- was in conformance with our previous report (data not
ence of Ang II, and cyclin E increased slightly. shown) [15, 16]. A dose-dependent increase of the pro-
Overexpression of p21CIP1, p27Kip1, and p16INK4 using tein expression was observed for each CDK inhibitor at
adenovirus vector 107, 108, and 109 pfu/ml, as shown in Figure 3. Judging
from the histologic staining of b-galactosidase, over 90%To further investigate whether this induction of CDK
inhibitors may contribute to hypertrophy of LLC-PK1 of the cells were transfected with adenoviral vector. As
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Fig. 4. Cell size analysis by forward light scatter of
AxCAp16-, AxCAp21-, AxCAp27-, and AxCA-
LacZ-infected LLC-PK1 cells. Effects of overexpres-
sion of p21CIP1, p27Kip1, and p16INK4 on the cell size of
LLC-PK1 cells were examined. (A) LLC-PK1 cells
were incubated with 109 pfu/ml of AxCAp16, Ax-
CAp21, AxCAp27, or AxCALacZ for 1 hour and
with 1028 m EGF or without EGF for 48 hours. Repre-
sentative tracing of relative cell number (plotted on
the y axis) as a function of forward light scatter (plot-
ted on the x axis) is shown. AxCAp16-, AxCAp21-,
AxCAp27-, AxCALacZ-, and AxCALacZ (without
EGF)-infected LLC-PK1 cells were represented as
blue line, orange line, red line, green line, and black
line, respectively. (B) The mean forward light scatter
is plotted on the y axis as a percentage of AxCALacZ-
treated cells after 48 hours of incubation with or
without 1028 m EGF (N 5 5, mean 6 sem). *Statisti-
cally significant difference (P , 0.05) compared with
value of AxCALacZ (with EGF)-infected LLC-PK1
cells.
plotting cell number as a function of forward light scatter,
and Figure 4B summarizes the data. The overexpression
of p21CIP1 and p27Kip1 significantly increased the mean
forward light scatter, but overexpression of p16INK4 did
not. We also used mean forward light scatter to compare
cell size in the presence and absence of EGF. As shown
in Figure 4A and B, there were no differences between
the two groups in cell size (mean forward light scatter).
To examine whether the increase in cell size was asso-
ciated with an increase in protein synthesis, we next
examined the effects of overexpression of p21CIP1, p27Kip1,
and p16INK4 on the protein synthesis. Cells were infected
with 109 pfu/ml concentrations of adenovirus for one hour
and were then incubated with 1028 m EGF or without
EGF for 48 hours. As shown in Figure 5, 109 pfu/ml con-
centrations of AxCAp21 and AxCAp27 infection signifi-
cantly increased [3H]-leucine incorporation, whereas Ax-
CAp16 infection did not effect any significant change.
In contrast to [3H]-leucine incorporation, [3H]-thymidine
incorporation was significantly decreased by the overex-
reported previously, the LDH release from the cells to pression of p16INK4 and was slightly decreased by the
the medium gave no indication of cytotoxic effects in overexpression of p21CIP1 and p27Kip1 (Fig. 5B). In the
the concentration of 109 pfu/ml [15, 16]. In the following absence of EGF, both [3H]-leucine and [3H]-thymidine
studies, we used the AxCAp16, AxCAp21, and Ax- incorporation were significantly decreased. AxCAp21
CAp27 adenoviruses at concentrations of 107, 108, and and AxCAp27 infection significantly increased the pro-
109 pfu/ml. tein:DNA ratio, and AxCAp16 did not. There was no
significant change in the protein:DNA ratio between the
Overexpression of p21CIP1 and p27Kip1 caused EGF-treated and untreated cells.
hypertrophy in LLC-PK1 cells
Effects of p21CIP1, p27Kip1, and p16INK4 overexpressionWe next investigated the effects of p21CIP1, p27Kip1, and
on CDK4 and CDK2 activityp16INK4 overexpression on cell size under stimulation of
EGF using mean forward light scatter, an index of cell To investigate further whether the overexpression of
p21CIP1, p27Kip1, and p16INK4 may functionally inhibitsize. Figure 4A illustrates a representative experiment
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Fig. 5. Effects of gene transfer of p21CIP1, p27KIP1, and 16INK4 on [3H]-leucine and [3H]-thymidine incorporation and the protein:DNA ratio in LLC-
PK1 cells. (A) LLC-PK1 cells were infected with 109 pfu/ml of AxCAp16, AxCAp21, AxCAp27, or AxCALacZ for 1 hour and incubated with
1028 m EGF or without EGF for 48 hours. For the last four hours, the cells were pulsed with 1 mCi [3H]-leucine. Incorporation values were adjusted
by measured protein values. (B) LLC-PK1 cells were infected with 109 pfu/ml of AxCAp16, AxCAp21, AxCAp27, or AxCALacZ for 1 hour and
incubated with 1028 m EGF or without EGF for 48 hours. For the last six hours, the cells were pulsed with 1 mCi [3H]-thymidine. Incorporation
values were adjusted by measured protein values. (C) LLC-PK1 cells were infected with 109 pfu/ml of AxCAp16, AxCAp21, AxCAp27, or
AxCALacZ for 1 hour and incubated with 1028 m EGF or without EGF for 48 hours. The ratio of protein:DNA is plotted on the y axis as a
percentage of control values (cells treated with EGF and AxCALacZ; (N 5 5, mean 6 sem). *Statistically significant difference (P , 0.05)
compared with value of AxCALacZ-infected LLC-PK1 cells.
cantly inhibited 1028 m EGF-stimulated CDK2 and
CDK4 enzyme activity to 17.2 6 5.2% and 15.6 6 5.7%,
respectively. Overexpression of p16INK4 significantly in-
hibited 1028 m EGF-stimulated CDK4 enzyme activity
to 21.9 6 6.7%, but it did not significantly change CDK2
enzyme activity. We observed marked decrease in CDK2
and CDK4 activity in the absence of EGF (Fig. 6).
DISCUSSION
This study demonstrates that Ang II caused hypertro-
Fig. 6. Effect of gene transfer of p21CIP1, p27KIP1, and 16INK4 on CDK2
phy of LLC-PK1 cells accompanying the increases ofkinase and CDK4 kinase activities of LLC-PK1 cells. LLC-PK1 cells
were infected with 109 pfu/ml of AxCAp16, AxCAp21, AxCAp27, or p27Kip1 and p21CIP1 protein levels, and that overexpression
AxCALacZ for 1 hour and were incubated for 48 hours with 1028 m of p27Kip1 and p21CIP1 also caused hypertrophy in LLC-
EGF or without EGF. Cell lysates were immunoprecipitated with anti-
PK1 cells. On the other hand, the overexpression ofCDK2 antibody. Immune complexes were assayed using Histon H1 as
a substrate (upper panel). LLC-PK1 cells were infected with 109 pfu/ml p16INK4 did not cause hypertrophy.
of AxCAp16, AxCAp21, AxCAp27, or AxCALacZ for 1 hour and Recently, a number of major advances in molecular
were incubated with 1028 m EGF or without EGF for 48 hours. Cell
biology have led to the identification of what are calledlysates were immunoprecipitated with anti-CDK4 antibody. Immune
complexes were assayed using GST-pRb as a substrate (lower panel). cyclins, a group of critical genetic and enzymatic path-
The blots represent four independent experiments with qualitatively ways that control cell cycling. Cyclins act in concert with
similar changes.
the CDKs to phosphorylate key substrates that facilitate
the passage of the cell through each phase of the cell
cycle [4–6]. A critical target of cyclin-CDK enzymes is
the retinoblastoma tumor suppresser protein, and phos-CDK2 and CDK4 enzyme activity, kinase activities were
phorylation of this protein inhibits its ability to restrainmeasured using Histon H1 or pRb as a substrate. Overex-
the activity of a family of transcription factors (E2F fam-pression of p21CIP1 significantly inhibited 1028 m EGF-
ily) that induces expression of genes important for cellstimulated CDK2 and CDK4 enzyme activity to 15.1 6
proliferation [4–6].4.5% and 14.1 6 4.7% of overexpression of LacZ, respec-
tively (Fig. 6). The overexpression of p27Kip1 also signifi- Cyclin-dependent kinases are negatively controlled by
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two distinct groups of inhibitory proteins, the CDK in- the failure of p16INK4 to induce hypertrophy. Overexpres-
sion of p16INK4 may cause cell cycle arrest at the earlyhibitors (CKIs). The first group, inhibitors of the CDK4
(INK4) family (including p16INK4a, p15INK4b, p18INK4c, and G1 phase by strong inhibition of CDK4. In this state,
very few cells may be retained at the late G1 phasep19INK4d), is specific for the G1 phase CDKs, CDK4 and
CDK6, and inhibits the kinase activity of the cyclin D/ because p16INK4 does not suppress CDK2. The possible
mechanism of hypertrophy is the incomplete inhibitionCDK4-CDK6 complexes on pRb [5, 10, 11, 22]. p16INK4
was first discovered as a 16 kDa protein that associates of CDK4 kinase by p21CIP1/p27Kip, and the progress of
cells goes into the late G1 phase. The difference of twowith CDK4. By binding to CDK4 or CDK6 but not to
cyclins or other known CDKs, recombinant p16INK4 forms groups, that is, p16INK4-overexpressed cells and p21CIP1/
p27Kip1-overexpressed cells, might have occurred at thea binary complex lacking kinase activity [5, 22].
The second CKIs family comprises p21CIP1, p27Kip1, and late G1 phase at the step of CDK2 activity. The cells
overexpressing p21CIP1 or p27Kip1 were blocked not onlyp57Kip2 (Kip family). Their inhibitory action affects a large
range of cyclin/CDK complexes involved in the G1 and at the early phase, but also at the late G1 via inhibition
of CDK2 activity. We postulated that these cells retainedS phases [5, 7–9, 12–14]. p21CIP1, a protein induced in part
by p53, is up-regulated by senescence, DNA damage, and at the late G1 phase may cause hypertrophy. On the
other hand, the cells that overexpressed p16INK4 were notcellular differentiation. p21CIP1 forms quaternary com-
plexes with CDKs, cyclins, and PCNA [7–9, 12]. retained at the late G1 phase at the step of CDK2 activity.
These cells were presumed not to show hypertrophicSeveral recent reports have demonstrated that cell
cycle regulators, especially CDK and CDK inhibitors, changes. These differences between the p21/p27 KIP
family and p16INK4 may support the idea of “cell-cycle–are closely related to hypertrophy in renal tubular cells
[1, 2, 17, 18]. Renal tubular hypertrophy occurs in a dependent hypertrophy” in renal tubular cells.
Preisig et al reported that there are two mechanisms ofnumber of clinical conditions such as diabetes mellitus,
chronic metabolic acidosis, and potassium depletion hypertrophy [1, 18, 19]. The first, hypertrophy associated
with alkalinization, is unrelated to increases in protein[1, 2]. In this study, we demonstrated clearly that p21CIP1
and p27Kip1 overexpression directly converted hyperpla- synthesis and occurs in the absence of active pRb. The
second is a “cell-cycle–dependent form of hypertrophy”sia to hypertrophy in renal tubular cells. Surprisingly,
however, overexpression of p16INK4 did not cause hyper- that requires the presence of active pRb or a related
family member. Wolf and Stahl reported that Ang IItrophy. One possible mechanism of hypertrophy by the
p21/p27 KIP family is the pattern of cell cycle entering stimulated hypertrophy and increased the p27KIP1 protein
level and that antisense oligonucleotide against p27KIP1into the growth phase from the G0 to G1 phase without
subsequent progress into the S phase. This may result inhibited Ang II-induced hypertrophy [17]. As with our
results, their report strongly suggested that p27KIP1 medi-in the synthesis of cell proteins but can be assumed to
prevent DNA synthesis and subsequent cell division. The ates hypertrophy of LLC-PK1 cells.
High glucose inhibits mesangial proliferation in vitrocommitment of cells to enter the S phase, the phase in
which DNA synthesis occurs, depends on the passage and induces hypertrophy in mesangial cells in culture
and in experimental diabetic nephropathy [29–32]. Inbeyond a distinct restriction (R) point late in the G1
phase [4, 25]. After passage through the R point, mito- this condition, Kuan et al reported that the expression
of p21CIP1 was increased, whereas the levels of p27KIP1genic growth factors are no longer required, and cells
progress to complete mitosis. If the cells do not pass the remained unchanged [30]. On the other hand, Wolf et
al reported that the expression of p27KIP1 was increasedR point and remain arrested in the late G1 phase, they
may undergo cellular hypertrophy. in hypertrophic glomeruli of db/db mouse [31]. Both
groups suggested the importance of the p21/p27 KIPThe levels of p27Kip1 and p21CIP1 protein expression are
high in cells arrested in the G1 phase, and their abun- family in the pathogenesis of hypertrophy, but there are
several discrepancies in their results. These differencesdance declines when the cells progress toward the S
phase of the cell cycle. p27Kip1 has been implicated in G1 may stem from differences in their experimental condi-
tions or the diabetic states of the mice. To confirm thatphase arrest induced by TGF-b, contact inhibition, or
deprivation of growth factors [9, 14, 26–28]. Thus, over- this p21/p27 KIP family could induce hypertrophy di-
rectly, we used adenovirus to overexpress these CDKexpression or accumulation of p27Kip1 or p21CIP1 may cause
cell cycle arrest in the late G1 phase and may induce inhibitors, taking advantage of its high transfection effi-
ciency. Through this means, we showed clearly that over-increases in the protein:DNA ratio and hypertrophic
change. On the other hand, overexpression of p16INK4 expression of p27Kip1 and p21CIP1 caused hypertrophy in
renal tubular cells, but that p16INK4 had no such effect.decreased [3H]-thymidine incorporation and [3H]-leucine
incorporation in our experiment. p16INK4 significantly in- In summary, we demonstrated that p27Kip1 and p21CIP1
may play an important role in hypertrophy of LLC-PK1hibited CDK4 activity but did not change CDK2 activity
[5, 22]. These findings offer one possible explanation for cells, but that p16INK4 did not cause any hypertrophic
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15. Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasakichanges in these cells. The complexity of the regulatory
S, Marumo F: Overexpression of cell cycle inhibitors (p16INK4
pathways of hypertrophic change has only begun to and p21Cip1) and cyclin D1 using adenovirus vectors regulates
proliferation of rat mesangial cells. J Am Soc Nephrol 8:51–60,emerge, and the results of this study provide a basis for
1997further investigation for basic and therapeutic ap-
16. Terada Y, Inoshita S, Nakashima O, Yamada T, Tamamori M,
proaches toward hypertrophic changes in renal diseases. Ito H, Sasaki S, Marumo F: Cyclin D1, p16, and retinoblastoma
gene regulate mitogenic signaling of endothelin in rat mesangial
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